Anchor Pointe Wealth Management’s Gilead Sciences GILD Stock Holding History

Anchor Pointe Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$245K	Buy	+2,667	New	+$240K	0.32%	61

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Anchor Pointe Wealth Management's GILD Position: Q4 2024 in Review

Anchor Pointe Wealth Management opened a new position in Gilead Sciences (GILD) in Q4 2024: 2,667 shares worth $245K. The stake represents 0.32% of the portfolio and ranks #61 among its holdings.

1,890 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

Anchor Pointe Wealth Management held 2,667 shares of Gilead Sciences worth $245K as of Q4 2024.
Gilead Sciences was a new Anchor Pointe Wealth Management position in Q4 2024.
Gilead Sciences made up 0.32% of Anchor Pointe Wealth Management's portfolio in Q4 2024, its #61 holding.
1,890 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Anchor Pointe Wealth Management's 13F filing for Q4 2024, filed 11 Mar 2025.